Cromwell Holdings’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
Cromwell Holdings's CORT Position: Q3 2026 in Review
Cromwell Holdings increased its Corcept Therapeutics (CORT) stake by 105% in Q3 2026, buying an estimated $2.26K and bringing the position to 41 shares worth $4.72K. The position accounts for ﹤0.01% of the portfolio, ranked #709.
Cromwell Holdings first reported a position in CORT in Q1 2026 and has held it in 3 quarters since. 497 funds tracked by Wall St. Rank hold CORT as of Q3 2026.
- Cromwell Holdings held 41 shares of Corcept Therapeutics worth $4.72K as of Q3 2026.
- Cromwell Holdings bought 21 Corcept Therapeutics shares in Q3 2026, an estimated $2.26K.
- Corcept Therapeutics made up ﹤0.01% of Cromwell Holdings's portfolio in Q3 2026, its #709 holding.
- Cromwell Holdings first reported a position in Corcept Therapeutics in Q1 2026 and has held it in 3 quarters since.
- 497 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.
Based on Cromwell Holdings's 13F filing for Q3 2026, filed 28 Oct 2026.